Form 4: Illumina VP Sells Shares for Tax Obligations
Insider Transaction Report
Illumina's VP, Chief Accounting Officer, Scott D. Ericksen, disposed of 206 shares of common stock to cover tax withholding obligations at a price of $122.44 per share.
Summary
- Scott D. Ericksen, VP, Chief Accounting Officer of Illumina, Inc. (ILMN), reported a transaction involving company common stock.
- On November 5, 2025, Ericksen disposed of 206 shares of Illumina Common Stock.
- The disposition was made at a price of $122.44 per share.
- This transaction was coded as 'F', indicating a disposition to the issuer to satisfy tax withholding obligations.
- Following this transaction, Ericksen beneficially owns 13,486 shares of Illumina Common Stock directly.
- The transaction was made pursuant to a Rule 10b5-1 plan.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction for tax withholding purposes, which is neutral in sentiment and does not indicate positive or negative company performance or outlook.
Positives
- The transaction was executed under a Rule 10b5-1 plan, indicating pre-planned sales to avoid accusations of insider trading.
- The disposition was for tax withholding, a common and routine event for executives receiving equity compensation.
Negatives
- A reduction in direct beneficial ownership by 206 shares.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This routine insider transaction for tax purposes is common across all industries for executives receiving equity compensation and does not reflect specific industry trends or competitive positioning for Illumina.
Comparison to Industry Standards
- The use of a Rule 10b5-1 plan for executive stock transactions is a standard best practice in corporate governance across publicly traded companies, aligning with industry norms for managing insider trading risks.
- Dispositions of shares to cover tax withholding obligations upon the vesting of equity awards are a standard and expected occurrence for executives in companies comparable to Illumina, such as Thermo Fisher Scientific (TMO) or Danaher Corporation (DHR), and do not indicate unusual activity.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 11/05/2025 | Indicates adherence to best practices for managing insider trading risks and provides an affirmative defense against potential claims. |
Stakeholder Impact
- Shareholders: Minimal impact, as it's a routine, pre-planned transaction for tax purposes by an executive. It does not signal a change in management's confidence or company fundamentals.
- Employees: No direct impact.
- Customers: No direct impact.
- Suppliers: No direct impact.
- Creditors: No direct impact.
Key Dates
| Date | Description |
|---|---|
| 11/05/2025 | Date of earliest transaction (disposition of shares) |
| 11/07/2025 | Date the Form 4 was signed and filed |
Keywords
Illumina, ILMN, Insider Trading, Form 4, Stock Sale, Tax Withholding, Executive Compensation, Scott D. Ericksen, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.